Netherlands at a glance
- Population
- 18.1 million 2025
- Life expectancy at birth
- 82.0 years, 2024
- People aged 65 and over
- 20.9 % of people, 2025
- Health spending per person
- 6,845 US$ per person, 2024
- Doctors
- 3.88 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
Netherlands Active Pharmaceutical Ingredients (API) Market Industry Trends and Forecast to 2034: Segmented by (Type, Source, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$2.07 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $3.48 Bn | — | — |
| 2025 (base) | $3.66 Bn | +$177.6 Mn | — |
| 2026 (forecast) | $3.85 Bn | +$186.6 Mn | +5.1% |
| 2027 (forecast) | $4.04 Bn | +$196.2 Mn | +10.5% |
| 2028 (forecast) | $4.25 Bn | +$206.2 Mn | +16.1% |
| 2029 (forecast) | $4.47 Bn | +$216.7 Mn | +22% |
| 2030 (forecast) | $4.69 Bn | +$227.7 Mn | +28.2% |
| 2031 (forecast) | $4.93 Bn | +$239.3 Mn | +34.8% |
| 2032 (forecast) | $5.18 Bn | +$251.5 Mn | +41.7% |
| 2033 (forecast) | $5.45 Bn | +$264.4 Mn | +48.9% |
| 2034 (forecast) | $5.73 Bn | +$277.9 Mn | +56.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $3.66 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $5.73 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type and source (see all) |
| Key players | Lonza Ltd, Pfizer CentreOne, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical, Dr Reddy’s Laboratories and 1 more (see all) |
| Regulator in the Netherlands | CBG-MEBSource: Medicines Evaluation Board (CBG-MEB). Checked 19 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Active pharmaceutical ingredients are the chemicals or biological substances in a medicine that give it its effect.
Key segments of the active pharmaceutical ingredients (API) market include type (Synthetic API, Biotech API and Highly Potent API) and source (Captive and Contract Manufactured).
Ageing populations, more chronic disease, broader access to medicines and steady new drug approvals are driving the active pharmaceutical ingredients (API) market.
Personalized treatments, local manufacturing and new technologies for making medicines give the active pharmaceutical ingredients (API) market room to grow.
Price controls, long and costly development, patent expiries and strict quality rules hold back the active pharmaceutical ingredients (API) market.
The active pharmaceutical ingredients (API) market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medicines are authorised either for the whole EU by the European Commission, after review by the European Medicines Agency (EMA), or nationally by the Medicines Evaluation Board (CBG-MEB).[1] Everyone must have basic health insurance from a private insurer, with a package set by law; the National Health Care Institute advises what it covers.[2]
[1] Medicines Evaluation Board (CBG-MEB). Checked 19 Nov 2026.
[2] National Health Care Institute (Zorginstituut Nederland). Checked 19 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for active pharmaceutical ingredients (API). Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in the Netherlands.
What doctors and scientists are doing in Active Pharmaceutical Ingredients (API) right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
Netherlands
Netherlands
Netherlands
Netherlands
Netherlands
Healthcare Services · Netherlands
Medical Devices · Netherlands
Healthcare Services · Netherlands
Healthcare Services · Global
Healthcare Services · Global
Healthcare Services · Global